TODAY'S PAPER
53° Good Afternoon
53° Good Afternoon
Business

Enzo prepares trial for new eye drug

Enzo

Enzo

Enzo BioChem Inc. will begin a clinical trial study of a new drug, Optiquel, for treatment of uveitis, a non-infectious inflammation of the eye, the company said Monday.

Enzo is a Manhattan company with a major division, Enzo Clinical Labs, in Farmingdale.

It said it filed an investigational new drug application with the Food and Drug Administration.

The company described the planned trial as a "randomized, double-masked, placebo-controlled study with a long-term follow-up."

The study will be conducted by the National Institute of Health's National Eye Institute. The principal investigator will be Dr. Robert Nussenblatt, chief of the institute's laboratory of immunology.
 

Comments

We're revamping our Comments section. Learn more and share your input.

More news